Skye Bioscience, Inc.
SKYE· Nasdaq
SKYESkye Bioscience, Inc.
Filed Aug 10, 2018 · 10-Q · 41 days after period end · 0001640334-18-001536
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Net Income | -$2.66M | -$702.76K | $573.09K | -$2.06M |
| EPS Diluted | -$0.02 | -$0.02 | $0.03 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 10, 2018 · 41 d after period end
